LONDON - The UK biotech sector did not get the bailout it hoped for in the 2009 budget, but it welcomed the chance to share in a £750 million (US$1.1 billion) strategic investment fund for emerging technologies. (BioWorld International) Read More
No Abstract BioWorld International CorrespondentProtAffin AG raised €14 million (US$18.3 million) in a Series B round to progress its early stage pipeline of novel, protein-based therapeutics that act by disrupting biological signaling between extracellular glycan structures and their protein ligands.The Graz, Austria-based company is adding 11 new staff on the strength of the new funding, boosting total headcount to 27 people. Read More
